Release Date: August 21, 2019 Expiration Date: August 31, 2020 (subject to change)
CE for this activity will not be available after this date.
Conference Level: ProficientOverview This presentation will be a 2019 update. The most recent nationally vetted standards for safe opioid prescribing are presented based on the FDA Prescriber Education blueprint and developed by the Collaboration for REMS Education (CO*RE). Content discusses the four phases of safe prescribing standards: (1) pain assessment and screening tool use guidelines; (2) opioid trial definition and expected components including UDT, PPA & Informed Consent; (3) long term therapy, UDT and screening tool use frequencies, and (4) aspects associated with termination of care. Concepts of Red Flag behaviors and problem cases are reviewed. Pharmacology information includes CO*RE content on immediate release and long acting opioids, dose and drug family changes, equal analgesic drug conversions and abuse deterrent medications. Completion of this program and its evaluation meets many state-based requirements, including Boards of Nursing, for opioid prescriber education.
This CE activity is a recording of a CE session from the AANP 2019 National Conference. It has been edited to meet the format requirements for online learning. If you received CE credit for attending the live session at Conference, you many not receive duplication credit for this same activity in a different format.CE Credit Instructions
Read this activity description, including objectives and disclosures.
Complete the educational content completely:
Video Presentations: Watch all video presentations completely.
Review all additional materials provided (handouts, posttest reviews, all other downloadable resources).
After completing all content:
Complete the posttest under Steps to Receive Credit.
Complete and submit the activity evaluation.
Describe the pathophysiology of pain as it relates to the concepts of pain management.
Accurately assess patients in pain.
Develop a safe and effective pain treatment plan.
Identify evidence-based non-opioid options for the treatment of pain.
Identify the risks and benefits of opioid therapy.
Manage ongoing opioid therapy.
Recognize behaviors that may be associated with opioid use disorder.
Faculty Randall S. Hudspeth, PHD, MBA, MS, APRN-CNP, FRE, FAANP Brett Badgley Snodgrass, FNP-C, CPE, FACPP, FAANP Disclosure This activity was planned in accordance with AANP Accreditation Standards and Policies. Dr. Hudspeth has no relevant affiliations to disclose. Brett Snodgrass discloses the following: Speaker’s bureau for Scilex Pharma and Salix and Consultant for Daiichi Sankyo
This educational activity may contain opinions of the speakers from their personal experience. The activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.Additional Information For questions about this online CE activity, or more information concerning the AANP CE Center, contact the AANP CE Center Manager at CECenter@aanp.org.
3 Contact Hour(s) of CE, All of which may be applied towards Pharmacology
Additional CE activities of interest
(OnDemand) Safe Opioid Prescribing Series: How to Safely and Effectively Treat Pain in Primary Care